Want to see IN:SHIVALIK full AI Analyst Report?

Shivalik Rasayan Ltd (SHIVALIK) Price & Analysis

0 Followers

SHIVALIK Stock Chart & Stats

₹358.75

-₹13.65(-1.86%)

At close: Jan 08 4:00 PM EST

₹358.75

-₹13.65(-1.86%)

Day’s Range― - ―

52-Week Range₹206.00 - ₹579.80

Previous CloseN/A

Volume18.40K

Average Volume (3M)1.25K

Market Cap

₹4.00B

Enterprise Value₹7.35K

Total Cash (Recent Filing)₹343.68M

Total Debt (Recent Filing)₹1.14B

Price to Earnings (P/E)33.8

Beta0.84

Next Earnings

Aug 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.2%

Share Statistics

EPS (TTM)7.55

Shares Outstanding15,750,365

10 Day Avg. Volume987

30 Day Avg. Volume1,247

Financial Highlights & Ratios

PEG Ratio-1.05

Price to Book (P/B)0.58

Price to Sales (P/S)0.94

P/FCF Ratio-5.96

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSustained top-line expansion across multiple years indicates durable demand for the company’s chemical intermediates. Persistent revenue growth supports capacity utilization, justifies ongoing investment in production, and reduces business risk tied to single-year fluctuations.

Conservative Balance SheetLow leverage and rising equity provide financial flexibility to fund operations, tolerate cyclical downturns, and pursue strategic capex or product investments without heavy refinancing pressure, supporting resilience over the medium term.

B2B Specialty Chemicals Business ModelServing specialized industrial customers creates structural demand, technical barriers and customer stickiness. Customized B2B intermediates tend to have higher switching costs and support stable, repeatable order streams versus commoditized chemical segments.

Bears Say

Negative Operating Cash FlowPersistent negative operating cash flow undermines internal funding for working capital, capex and growth. Over months this raises reliance on external financing or reserves, increasing liquidity risk and constraining the company’s ability to reinvest or smooth capital-intensive cycles.

Persistent Negative Free Cash FlowOngoing negative free cash flow limits the firm’s capacity to reduce debt, pay sustainable dividends, or fund strategic initiatives from operations. It signals structural cash-conversion issues that may require recurring financing and reduce margin of safety over the medium term.

Weakened Profitability And ROEDeclining margins and low single-digit ROE indicate reduced efficiency converting capital into profits. Over time this can lower returns for shareholders, limit internal funding for expansion, and suggest competitive or cost-pressure issues that could be structural if not addressed.

Shivalik Rasayan Ltd News

Shivalik Rasayan Publishes Audited Results for Quarter and Year Ended March 31, 2026

An announcement from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ) is now available. Shivalik Rasayan Limited announced that its...

2M ago

Shivalik Rasayan Limited Publishes Regulatory Advertisements

The latest update is out from Shivalik Rasayan Ltd ( ($IN:SHIVALIK) ). Shivalik Rasayan Limited announced the publication...

10M ago

SHIVALIK FAQ

What was Shivalik Rasayan Ltd’s price range in the past 12 months?

Shivalik Rasayan Ltd lowest stock price was ₹206.00 and its highest was ₹579.80 in the past 12 months.

What is Shivalik Rasayan Ltd’s market cap?

Shivalik Rasayan Ltd’s market cap is ₹4.00B.

When is Shivalik Rasayan Ltd’s upcoming earnings report date?

Shivalik Rasayan Ltd’s upcoming earnings report date is Aug 14, 2026 which is in 4 days.

How were Shivalik Rasayan Ltd’s earnings last quarter?

Shivalik Rasayan Ltd released its earnings results on May 27, 2026. The company reported ₹2.87 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.87.

Is Shivalik Rasayan Ltd overvalued?

According to Wall Street analysts Shivalik Rasayan Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Shivalik Rasayan Ltd pay dividends?

Shivalik Rasayan Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.2%. See more information on Shivalik Rasayan Ltd dividends here

What is Shivalik Rasayan Ltd’s EPS estimate?

Shivalik Rasayan Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shivalik Rasayan Ltd have?

Shivalik Rasayan Ltd has 15,750,365 shares outstanding.

What happened to Shivalik Rasayan Ltd’s price movement after its last earnings report?

Shivalik Rasayan Ltd reported an EPS of ₹2.87 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.956%.

Which hedge fund is a major shareholder of Shivalik Rasayan Ltd?

Currently, no hedge funds are holding shares in IN:SHIVALIK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Shivalik Rasayan Ltd

Established on March 16, 1979, by Rahul Bishnoi, Shivalik Rasayan Limited is an Indian firm specializing in the creation of pharmaceutical and agrochemical products. Based in New Delhi, its offerings notably feature organophosphorous-based insecticides and various other chemicals.